Prospective comparison of [(18)F]AlF-NOTA-octreotide PET/MRI to [(68)Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients

BACKGROUND: Fluorine-18-labeled SSAs have the potential to become the next-generation tracer in SSTR-imaging in neuroendocrine tumor (NET) patients given their logistical advantages over the current gold standard gallium-68-labeled SSAs. In particular, [(18)F]AlF-OC has already shown excellent clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Boeckxstaens, Lennert, Pauwels, Elin, Vandecaveye, Vincent, Deckers, Wies, Cleeren, Frederik, Dekervel, Jeroen, Vandamme, Timon, Serdons, Kim, Koole, Michel, Bormans, Guy, Laenen, Annouschka, Clement, Paul M., Geboes, Karen, Van Cutsem, Eric, Nackaerts, Kristiaan, Stroobants, Sigrid, Verslype, Chris, Van Laere, Koen, Deroose, Christophe M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235004/
https://www.ncbi.nlm.nih.gov/pubmed/37261615
http://dx.doi.org/10.1186/s13550-023-01003-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235004/
https://www.ncbi.nlm.nih.gov/pubmed/37261615
http://dx.doi.org/10.1186/s13550-023-01003-3

Ejemplares similares